Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: An Assessment of Long Term Neurocognitive, Neuroendocrine Adn Ototoxicity Outcomes

NCT01288235 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01288235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01288235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: An Assessment of Long Term Neurocognitive, Neuroendocrine Adn Ototoxicity Outcomes
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2011
Completion date
September 30, 2016
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, brain tumor, ependymoma, ganglioglioma, low grade glioma